Symbol | Market cap | Price | Change % | Volume | Rel Volume | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst Rating |
---|---|---|---|---|---|---|---|---|---|---|---|
LLYEli Lilly and Company | 764.19 B USD | 804.99 USD | −0.39% | 2.81 M | 0.58 | 88.06 | 9.14 USD | +68.74% | 0.64% | Health technology | Buy |
NVONovo Nordisk A/S DR | 388 B USD | 85.19 USD | −2.67% | 9.53 M | 0.82 | 27.62 | 3.08 USD | +28.16% | 1.17% | Health technology | Buy |
JNJJohnson & Johnson | 362.06 B USD | 150.38 USD | −1.65% | 10.31 M | 0.94 | 25.94 | 5.80 USD | +3.95% | 3.21% | Health technology | Buy |
ABBVAbbVie Inc. | 308.91 B USD | 174.81 USD | −1.18% | 5.6 M | 0.83 | 60.96 | 2.87 USD | −21.52% | 3.50% | Health technology | Buy |
MRKMerck & Company, Inc. | 246.51 B USD | 97.45 USD | −0.50% | 12.84 M | 1.05 | 20.41 | 4.77 USD | +165.21% | 3.19% | Health technology | Buy |
AZNAstraZeneca PLC DR | 216.62 B USD | 69.59 USD | −0.70% | 3.43 M | 0.62 | 33.44 | 2.08 USD | +10.04% | 2.08% | Health technology | Strong buy |
NVSNovartis AG DR | 202.45 B USD | 101.84 USD | −1.52% | 2.03 M | 1.10 | 11.88 | 8.57 USD | +130.62% | 3.09% | Health technology | Neutral |
PFEPfizer, Inc. | 151.59 B USD | 26.75 USD | −0.41% | 40.58 M | 1.13 | 35.96 | 0.74 USD | −59.14% | 6.25% | Health technology | Buy |
SNYSanofi DR | 133.41 B USD | 52.97 USD | −0.69% | 2.12 M | 0.80 | 29.20 | 1.81 USD | −49.14% | 2.77% | Health technology | Buy |
BMYBristol-Myers Squibb Company | 119.18 B USD | 58.76 USD | −3.07% | 9.23 M | 0.94 | — | −3.60 USD | −191.22% | 3.96% | Health technology | Buy |
VRTXVertex Pharmaceuticals Incorporated | 113.49 B USD | 440.68 USD | −0.72% | 1.16 M | 0.74 | — | −1.99 USD | −114.96% | 0.00% | Health technology | Buy |
ZTSZoetis Inc. | 76.89 B USD | 170.42 USD | −1.51% | 2.16 M | 0.72 | 32.04 | 5.32 USD | +8.17% | 1.00% | Health technology | Buy |
REGNRegeneron Pharmaceuticals, Inc. | 75.42 B USD | 686.33 USD | +0.24% | 640.37 K | 0.62 | 16.98 | 40.41 USD | +15.25% | 0.00% | Health technology | Buy |
GSKGSK plc DR | 71.49 B USD | 35.10 USD | −1.13% | 4.55 M | 1.01 | 22.84 | 1.54 USD | −57.75% | 4.31% | Health technology | Neutral |
TAKTakeda Pharmaceutical Company Limited DR | 41.98 B USD | 13.37 USD | +0.15% | 1.55 M | 0.87 | 22.18 | 0.60 USD | +36.22% | 3.79% | Health technology | Buy |
ALNYAlnylam Pharmaceuticals, Inc. | 36.01 B USD | 279.19 USD | +0.89% | 611.31 K | 0.75 | — | −2.62 USD | +36.82% | 0.00% | Health technology | Buy |
ONCBeiGene, Ltd. DR | 24.85 B USD | 226.67 USD | +0.63% | 209.15 K | 0.51 | — | −8.24 USD | +11.11% | 0.00% | Health technology | Strong buy |
BIIBBiogen Inc. | 21.2 B USD | 145.49 USD | −2.20% | 1.3 M | 0.97 | 13.14 | 11.07 USD | +10.06% | 0.00% | Health technology | Buy |
RPRXRoyalty Pharma plc | 18.82 B USD | 31.94 USD | +0.69% | 6.88 M | 1.46 | 12.49 | 2.56 USD | +538.81% | 2.65% | Health technology | Strong buy |
UTHRUnited Therapeutics Corporation | 16.56 B USD | 370.85 USD | +0.35% | 320.22 K | 1.05 | 16.29 | 22.77 USD | +25.44% | 0.00% | Health technology | Buy |
NBIXNeurocrine Biosciences, Inc. | 15.26 B USD | 150.71 USD | +1.70% | 1.1 M | 1.12 | 40.37 | 3.73 USD | +99.71% | 0.00% | Health technology | Strong buy |
INCYIncyte Corporation | 14.09 B USD | 73.15 USD | +0.70% | 995.24 K | 0.78 | 518.06 | 0.14 USD | −92.50% | 0.00% | Health technology | Buy |
INSMInsmed Incorporated | 14.04 B USD | 78.46 USD | +1.07% | 2.06 M | 0.98 | — | −5.56 USD | −5.41% | 0.00% | Health technology | Strong buy |
ITCIIntra-Cellular Therapies Inc. | 13.49 B USD | 127.00 USD | −0.17% | 2.05 M | 0.21 | — | −0.86 USD | +47.14% | 0.00% | Health technology | Buy |
GMABGenmab A/S DR | 13.45 B USD | 19.58 USD | −5.87% | 5.38 M | 4.05 | 18.86 | 1.04 USD | +10.05% | 0.00% | Health technology | Buy |
VTRSViatris Inc. | 13.37 B USD | 11.20 USD | −1.93% | 8.13 M | 0.84 | — | −0.74 USD | −148.99% | 4.20% | Health technology | Neutral |
RDYDr. Reddy's Laboratories Ltd DR | 11.56 B USD | 13.53 USD | −0.88% | 1.7 M | 0.73 | 17.59 | 0.77 USD | +1.40% | 0.59% | Health technology | Neutral |
SRPTSarepta Therapeutics, Inc. | 11.22 B USD | 117.51 USD | +0.53% | 1.22 M | 1.26 | 97.62 | 1.20 USD | — | 0.00% | Health technology | Strong buy |
RGENRepligen Corporation | 9.76 B USD | 174.24 USD | +3.71% | 1.12 M | 1.89 | — | −0.15 USD | −108.32% | 0.00% | Health technology | Buy |
EXELExelixis, Inc. | 9.31 B USD | 32.60 USD | −0.40% | 2.99 M | 0.92 | 20.77 | 1.57 USD | +459.23% | 0.00% | Health technology | Buy |
ROIVRoivant Sciences Ltd. | 8.12 B USD | 11.15 USD | +0.09% | 2.29 M | 0.53 | 1.97 | 5.66 USD | — | 0.00% | Health technology | Strong buy |
ASNDAscendis Pharma A/S DR | 7.53 B USD | 129.37 USD | +2.63% | 203.49 K | 0.39 | — | −8.10 USD | +28.89% | 0.00% | Health technology | Strong buy |
JAZZJazz Pharmaceuticals plc | 7.47 B USD | 123.53 USD | −0.69% | 492.62 K | 1.01 | 17.79 | 6.94 USD | +1,051.97% | 0.00% | Health technology | Strong buy |
MDGLMadrigal Pharmaceuticals, Inc. | 7.14 B USD | 327.35 USD | +5.28% | 385.84 K | 0.62 | — | −25.07 USD | −30.31% | 0.00% | Health technology | Strong buy |
LEGNLegend Biotech Corporation DR | 6.72 B USD | 36.01 USD | −1.72% | 636.4 K | 0.44 | — | −1.91 USD | +35.99% | 0.00% | Health technology | Strong buy |
CORTCorcept Therapeutics Incorporated | 6.36 B USD | 60.66 USD | +0.60% | 492.97 K | 0.55 | 48.24 | 1.26 USD | +55.35% | 0.00% | Health technology | Strong buy |
CYTKCytokinetics, Incorporated | 5.75 B USD | 48.70 USD | −2.48% | 862.85 K | 0.65 | — | −5.39 USD | +2.40% | 0.00% | Health technology | Strong buy |
GRFSGrifols, S.A. DR | 5.68 B USD | 7.19 USD | −0.69% | 679.83 K | 0.79 | — | — | — | 0.00% | Health technology | Neutral |
IONSIonis Pharmaceuticals, Inc. | 5.39 B USD | 34.11 USD | +0.18% | 1.28 M | 0.71 | — | −2.44 USD | +14.63% | 0.00% | Health technology | Buy |
TGTXTG Therapeutics, Inc. | 5.21 B USD | 33.45 USD | +4.79% | 3.44 M | 1.28 | — | −0.11 USD | +60.71% | 0.00% | Health technology | Strong buy |
ALKSAlkermes plc | 5.06 B USD | 31.25 USD | −0.86% | 1.69 M | 1.13 | 15.92 | 1.96 USD | +59.05% | 0.00% | Health technology | Buy |
VRNAVerona Pharma plc DR | 4.39 B USD | 53.22 USD | −0.88% | 988.37 K | 0.70 | — | −1.94 USD | −197.56% | 0.00% | Health technology | Strong buy |
OGNOrganon & Co. | 4.14 B USD | 16.06 USD | −1.23% | 2.03 M | 0.86 | 3.19 | 5.04 USD | +120.60% | 6.89% | Health technology | Neutral |
RAREUltragenyx Pharmaceutical Inc. | 3.92 B USD | 42.49 USD | −1.80% | 553.39 K | 0.51 | — | −6.46 USD | +28.02% | 0.00% | Health technology | Strong buy |
PBHPrestige Consumer Healthcare Inc. | 3.92 B USD | 79.35 USD | +0.20% | 231.18 K | 0.88 | 19.33 | 4.11 USD | — | 0.00% | Health technology | Buy |
BHVNBiohaven Ltd. | 3.88 B USD | 38.37 USD | −3.91% | 948.56 K | 0.93 | — | −9.35 USD | −37.39% | 0.00% | Health technology | Strong buy |
VKTXViking Therapeutics, Inc. | 3.82 B USD | 34.32 USD | +2.57% | 2.36 M | 0.50 | — | −0.94 USD | −1.31% | 0.00% | Health technology | Strong buy |
APLSApellis Pharmaceuticals, Inc. | 3.64 B USD | 29.28 USD | −1.71% | 2.59 M | 1.47 | — | −2.04 USD | +61.20% | 0.00% | Health technology | Buy |
AKROAkero Therapeutics, Inc. | 3.59 B USD | 51.47 USD | −0.46% | 5.23 M | 2.11 | — | −3.75 USD | −59.03% | 0.00% | Health technology | Strong buy |
CRNXCrinetics Pharmaceuticals, Inc. | 3.54 B USD | 38.22 USD | +0.03% | 808.34 K | 0.59 | — | −3.72 USD | −2.14% | 0.00% | Health technology | Strong buy |
PTCTPTC Therapeutics, Inc. | 3.49 B USD | 45.19 USD | −1.91% | 390.05 K | 0.56 | — | −5.94 USD | +31.43% | 0.00% | Health technology | Buy |
PRGOPerrigo Company plc | 3.38 B USD | 24.79 USD | −1.43% | 1.1 M | 0.87 | — | −1.11 USD | −34,712.50% | 4.39% | Health technology | Buy |
ACADACADIA Pharmaceuticals Inc. | 3.06 B USD | 18.40 USD | +0.71% | 1.54 M | 0.80 | 23.82 | 0.77 USD | — | 0.00% | Health technology | Buy |
XENEXenon Pharmaceuticals Inc. | 3.05 B USD | 40.00 USD | −0.27% | 472.83 K | 1.20 | — | −2.81 USD | −5.62% | 0.00% | Health technology | Strong buy |
VCELVericel Corporation | 2.97 B USD | 60.11 USD | +0.65% | 629.5 K | 1.30 | 961.76 | 0.06 USD | — | 0.00% | Health technology | Strong buy |
FOLDAmicus Therapeutics, Inc. | 2.89 B USD | 9.66 USD | −0.21% | 1.96 M | 0.85 | — | −0.35 USD | +41.95% | 0.00% | Health technology | Buy |
MLTXMoonLake Immunotherapeutics | 2.88 B USD | 45.11 USD | +0.49% | 347.07 K | 0.54 | — | −1.29 USD | −36.77% | 0.00% | Health technology | Strong buy |
CPRXCatalyst Pharmaceuticals, Inc. | 2.72 B USD | 22.84 USD | +0.62% | 624.14 K | 0.39 | 19.49 | 1.17 USD | +122.28% | 0.00% | Health technology | Strong buy |
AMRXAmneal Pharmaceuticals, Inc. | 2.7 B USD | 8.73 USD | −1.02% | 589.27 K | 0.45 | — | −0.68 USD | −1,181.67% | 0.00% | Health technology | Buy |
HCMHUTCHMED (China) Limited DR | 2.37 B USD | 13.50 USD | −1.03% | 41.35 K | 0.37 | — | −0.25 USD | −16.10% | 0.00% | Health technology | Strong buy |
MIRMMirum Pharmaceuticals, Inc. | 2.33 B USD | 48.54 USD | +0.12% | 326.61 K | 0.53 | — | −2.07 USD | +52.00% | 0.00% | Health technology | Strong buy |
NAMSNewAmsterdam Pharma Company N.V. | 2.29 B USD | 21.45 USD | −5.13% | 365.8 K | 0.53 | — | — | — | 0.00% | Health technology | Strong buy |
IBRXImmunityBio, Inc. | 2.25 B USD | 3.08 USD | −1.60% | 3.46 M | 0.45 | — | −0.89 USD | +15.29% | 0.00% | Health technology | Buy |
LGNDLigand Pharmaceuticals Incorporated | 2.23 B USD | 118.11 USD | +0.71% | 52.47 K | 0.54 | 46.99 | 2.51 USD | +200.39% | 0.00% | Health technology | Strong buy |
HRMYHarmony Biosciences Holdings, Inc. | 2.19 B USD | 38.42 USD | +0.44% | 519.66 K | 0.74 | 18.19 | 2.11 USD | −14.38% | 0.00% | Health technology | Strong buy |
CNTACentessa Pharmaceuticals plc DR | 2.16 B USD | 16.59 USD | +1.04% | 795.17 K | 1.65 | — | −1.53 USD | +7.72% | 0.00% | Health technology | Strong buy |
SUPNSupernus Pharmaceuticals, Inc. | 2.16 B USD | 39.15 USD | −0.66% | 212.47 K | 0.71 | 36.65 | 1.07 USD | +175.07% | 0.00% | Health technology | Buy |
SLNOSoleno Therapeutics, Inc. | 2.11 B USD | 48.98 USD | +4.64% | 183.96 K | 0.39 | — | −3.31 USD | −2.66% | 0.00% | Health technology | Strong buy |
IDYAIDEAYA Biosciences, Inc. | 2.06 B USD | 23.86 USD | +0.25% | 1.1 M | 1.23 | — | −2.33 USD | −19.54% | 0.00% | Health technology | Strong buy |
TARSTarsus Pharmaceuticals, Inc. | 1.95 B USD | 51.06 USD | −0.76% | 328.45 K | 0.48 | — | −3.81 USD | +0.54% | 0.00% | Health technology | Strong buy |
AGIOAgios Pharmaceuticals, Inc. | 1.91 B USD | 33.55 USD | −0.59% | 457.84 K | 0.68 | 2.95 | 11.37 USD | — | 0.00% | Health technology | Buy |
TVTXTravere Therapeutics, Inc. | 1.84 B USD | 21.10 USD | +4.82% | 1.34 M | 0.99 | — | −4.56 USD | −3.48% | 0.00% | Health technology | Strong buy |
AMPHAmphastar Pharmaceuticals, Inc. | 1.78 B USD | 37.12 USD | +0.03% | 444.82 K | 0.79 | 12.35 | 3.01 USD | +17.33% | 0.00% | Health technology | Buy |
BLTEBelite Bio, Inc DR | 1.77 B USD | 59.14 USD | +3.16% | 24.81 K | 0.56 | — | −1.11 USD | — | 0.00% | Health technology | Strong buy |
MNKDMannKind Corporation | 1.69 B USD | 6.11 USD | +0.33% | 1.21 M | 0.58 | 86.91 | 0.07 USD | — | 0.00% | Health technology | Strong buy |
ARQTArcutis Biotherapeutics, Inc. | 1.63 B USD | 13.93 USD | −2.25% | 1.31 M | 0.67 | — | −1.79 USD | +59.00% | 0.00% | Health technology | Strong buy |
AAAPGAscentage Pharma Group International - American Depository Shares DR | 1.53 B USD | 17.20 USD | −0.29% | 39.82 K | — | — | −0.70 USD | +63.05% | 0.00% | Health technology | — |
EVOEvotec SE DR | 1.53 B USD | 4.20 USD | −3.23% | 68.1 K | 1.44 | — | −0.52 USD | +5.42% | 0.00% | Health technology | Buy |
VRDNViridian Therapeutics, Inc. | 1.52 B USD | 19.21 USD | +1.59% | 935.87 K | 0.87 | — | −4.31 USD | +15.56% | 0.00% | Health technology | Strong buy |
INDVIndivior PLC | 1.52 B USD | 12.22 USD | +1.66% | 1.53 M | 1.37 | — | −0.04 USD | +97.57% | 0.00% | Health technology | Strong buy |
KNSAKiniksa Pharmaceuticals, Ltd. | 1.46 B USD | 20.18 USD | −2.79% | 578.34 K | 0.91 | — | −0.14 USD | −32.91% | 0.00% | Health technology | Strong buy |
SPRYARS Pharmaceuticals, Inc. | 1.45 B USD | 14.88 USD | +2.98% | 1.42 M | 0.92 | — | −0.51 USD | +79.10% | 0.00% | Health technology | Strong buy |
PRAXPraxis Precision Medicines, Inc. | 1.4 B USD | 75.36 USD | +2.81% | 128.47 K | 0.32 | — | −10.30 USD | +69.41% | 0.00% | Health technology | Strong buy |
NRIXNurix Therapeutics, Inc. | 1.39 B USD | 19.56 USD | −1.26% | 577.08 K | 0.85 | — | −2.91 USD | −5.94% | 0.00% | Health technology | Strong buy |
DAWNDay One Biopharmaceuticals, Inc. | 1.33 B USD | 13.21 USD | +3.45% | 1.24 M | 0.89 | — | −1.01 USD | +55.62% | 0.00% | Health technology | Strong buy |
ARDXArdelyx, Inc. | 1.3 B USD | 5.49 USD | +0.37% | 2.66 M | 0.44 | — | −0.31 USD | −149.72% | 0.00% | Health technology | Strong buy |
OCULOcular Therapeutix, Inc. | 1.24 B USD | 7.90 USD | +0.13% | 616.56 K | 0.68 | — | −1.32 USD | −18.71% | 0.00% | Health technology | Strong buy |
LQDALiquidia Corporation | 1.2 B USD | 14.20 USD | +1.36% | 769.84 K | 0.70 | — | −1.62 USD | −82.56% | 0.00% | Health technology | Strong buy |
PCRXPacira BioSciences, Inc. | 1.19 B USD | 25.75 USD | +0.35% | 1.14 M | 1.20 | — | −2.05 USD | −2,733.63% | 0.00% | Health technology | Neutral |
INVAInnoviva, Inc. | 1.18 B USD | 18.79 USD | −1.00% | 375.97 K | 0.50 | 27.32 | 0.69 USD | +55.68% | 0.00% | Health technology | Buy |
HROWHarrow, Inc. | 1.16 B USD | 32.70 USD | +1.27% | 227.75 K | 0.72 | — | −0.94 USD | −108.90% | 0.00% | Health technology | Strong buy |
ETNB89bio, Inc. | 1.06 B USD | 9.01 USD | +0.11% | 7.34 M | 1.95 | — | −2.91 USD | −45.57% | 0.00% | Health technology | Strong buy |
COLLCollegium Pharmaceutical, Inc. | 1.06 B USD | 32.76 USD | −3.39% | 191.39 K | 0.47 | 14.13 | 2.32 USD | +1,442.05% | 0.00% | Health technology | Strong buy |
ZYMEZymeworks Inc. | 1.01 B USD | 14.56 USD | +0.76% | 246.65 K | 0.62 | — | −1.51 USD | −148.37% | 0.00% | Health technology | Buy |
GYREGyre Therapeutics, Inc. | 1.01 B USD | 11.74 USD | +3.16% | 49.73 K | 0.64 | — | — | — | 0.00% | Health technology | — |
PHVSPharvaris N.V. | 972.14 M USD | 18.00 USD | −0.11% | 27.9 K | 0.45 | — | −2.68 USD | +16.70% | 0.00% | Health technology | Strong buy |
AVBPArriVent BioPharma, Inc. | 970.48 M USD | 28.80 USD | +1.98% | 214.08 K | 1.54 | — | −2.42 USD | −38.12% | 0.00% | Health technology | Strong buy |
BGMBGM Group Ltd. | 958.61 M USD | 9.86 USD | −6.54% | 26.9 K | 0.36 | — | — | — | 0.00% | Health technology | — |
OCSOculis Holding AG | 932.17 M USD | 22.33 USD | +1.36% | 62.36 K | 0.47 | — | −2.01 USD | — | 0.00% | Health technology | Strong buy |
EOLSEvolus, Inc. Common Stock | 901.06 M USD | 14.23 USD | −3.59% | 1 M | 1.02 | — | −0.91 USD | +17.74% | 0.00% | Health technology | Strong buy |